You are here

  • Home
  • Archive
  • Volume 70, Issue Suppl 3
  • S55 Towards the Clinical Application of Anti-pseudomonal Bacteriophage: Activity is Retained Following Nebulisation with a Range of Commercially Available Nebuliser Systems

Article metrics

Article menu

Download PDFPDF

Spoken sessions
Advances in cystic fibrosis
S55 Towards the Clinical Application of Anti-pseudomonal Bacteriophage: Activity is Retained Following Nebulisation with a Range of Commercially Available Nebuliser Systems
Free

 

Online download statistics by month:

Online download statistics by month: November 2015 to March 2024

AbstractFullPdf
Nov 20151200
Dec 20151901
Jan 20161601
Feb 2016707
Mar 20161302
Apr 2016801
May 20162400
Jun 2016802
Jul 2016408
Aug 2016704
Sep 20161802
Oct 20162001
Nov 20161507
Dec 20161003
Jan 20172402
Feb 2017703
Mar 201719013
Apr 2017204
May 201711010
Jun 2017504
Jul 2017400
Aug 20172809
Sep 20171004
Oct 20171802
Nov 20171200
Dec 20172205
Jan 2018801
Feb 2018801
Mar 20181400
Apr 20181000
May 20181200
Jun 20185402
Jul 20188000
Aug 20187800
Sep 20186800
Oct 20186602
Nov 20186405
Dec 20186200
Jan 20196000
Feb 20196000
Mar 20196602
Apr 20194600
May 20191801
Jun 20192401
Jul 20192201
Aug 20193300
Sep 20193402
Oct 20192201
Nov 20192805
Dec 20192004
Jan 20203102
Feb 20202002
Mar 20202102
Apr 20201603
May 20202301
Jun 20202601
Jul 20202403
Aug 20201703
Sep 20202902
Oct 20203601
Nov 20201404
Dec 20202000
Jan 20211802
Feb 20211803
Mar 20211601
Apr 20212404
May 2021600
Jun 2021104
Jul 2021002
Aug 2021003
Sep 2021004
Oct 202130018
Nov 20212009
Dec 20212402
Jan 20221200
Feb 20222603
Mar 20222402
Apr 20223300
May 20222204
Jun 20224802
Jul 20223401
Aug 20223003
Sep 20222803
Oct 20222005
Nov 20222805
Dec 20222800
Jan 20232201
Feb 20231800
Mar 20233000
Apr 20232801
May 20232103
Jun 20231600
Jul 20232402
Aug 20232600
Sep 20232702
Oct 20232200
Nov 20232701
Dec 20232801
Jan 20242203
Feb 20242400
Mar 20242001
Total24220242